Search results
2 results found Showing page 1 of 1
-
Valeant needs some painkillers after a Monday to forget
8 years ago
Beleaguered drugmaker Valeant Pharmaceuticals – one of the most widely-held names in the CLO market – was subject to yet more unwanted headlines yesterday -
CLOs may need treatment as Valeant's stock plummets
8 years ago
CLOs could be in for testing times after damaging allegations against widely-held leveraged loan issuer Valeant Pharmaceuticals were published yesterday
2 results found Showing page 1 of 1
Want all the latest news, comment, analysis and data?